IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,447,850 | -40.5% | 1,448,432 | -2.1% | 0.00% | – |
| Q2 2023 | $4,111,489 | +40.0% | 1,478,953 | -8.3% | 0.00% | – |
| Q1 2023 | $2,936,000 | +37681.5% | 1,613,297 | +5.2% | 0.00% | -100.0% |
| Q4 2022 | $7,771 | -99.9% | 1,533,127 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $7,769,000 | +79.8% | 1,563,263 | +34.5% | 0.00% | 0.0% |
| Q2 2022 | $4,322,000 | -35.2% | 1,161,894 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $6,671,000 | -13.7% | 1,189,163 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $7,729,000 | -33.6% | 1,271,192 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $11,643,000 | +30.9% | 1,195,309 | +91.9% | 0.00% | 0.0% |
| Q2 2021 | $8,896,000 | -31.1% | 623,024 | +14.6% | 0.00% | -50.0% |
| Q1 2021 | $12,908,000 | – | 543,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |